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Abstract: The bulbs of Ledebouria socialis (Hyacinthaceae) yielded the novel 
benzocyclobutene homoisoflavonoid, (R)-2’,5-dihydroxy-3’,4’,7-
trimethoxyspiro{2H-1-benzopyran-3-(4H)-9-bicyclo[4.2.0]octa[1,3,5]triene}-4-one, 
socialinone (1). Ledebouria ovatifolia yielded (2ε,3R)-2,5-dihydroxy-7-
methoxyspiro[2H-1-benzopyran-3(4H), 5’(6’H)-cyclobuta[f][1,3]benzodioxol]-4-one 
(2) and the novel homoisoflavanone, (E)-3-(3’,4’-dihydroxybenzylidene)-5,7-
dihydroxychroman-4-one, ovatifolionone (5), the novel dihydrochalcone, 4,4’-
dihydroxy-2’,6’-dimethoxydihydrochalcone (3), and xanthone, 1,6-dihydroxy-2,3,5-
trimethoxy-8-methyl-9H-xanthen-9-one (4) along with twenty-one known 
compounds. Structures were determined using spectroscopic techniques. The anti-
inflammatory activities of the homoisoflavonoids and xanthones isolated were 
evaluated against cyclooxygenase-1 and -2 isoenzymes. (R)-3-(3’,4’-
Dihydroxybenzyl)-7-hydroxy-5-methoxychroman-4-one (7), (E)-3-(3’,4’-
dihydroxybenzylidene)-7-hydroxy-5-methoxychroman-4-one (10), 1,3,6-trihydroxy-
2-methoxy-8-methylxanthen-9-one (6) and ovatifolionone acetate (5Ac) exhibited 
significant activity against cyclooxygenase-2 at <10 µM.   
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1. Introduction: 
Ledebouria Roth of the Hyacinthaceae is a genus consisting of approx. 60 species, 
mostly sub-Saharan, with one or two species each in Madagascar and India, and with 
its centre of diversity in northeastern South Africa (Venter, 2008).  Ledebouria was 
previously considered congeneric with a broadly conceived Scilla L. but subsequently 
reinstated by Jessop (1970). In previous pharmacological investigations, 
homoisoflavanones, commonly occurring constituents in the Hyacinthoideae (Speta 
1998; Pohl et al., 2000), have been found to have anti-inflammatory activity (Della 
Loggia et al., 1989; Abegaz et al., 2007).  
 
The phytochemistry of several members of Ledebouria have been investigated 
previously (Pohl et al., 2000, 2001; Mutanyatta et al., 2003), including both species 
reported in the current account.  The widespread Ledebouria ovatifolia (Bak.) Jessop 
exhibits high polymorphism, with several entities currently synonymised under this 
name. This prompted a re-investigation of this species.  The bulbs of L. ovatifolia are 
used in African traditional medicine to treat backache, influenza and gastro-enteritis 
(Hutchings et al., 1996); it is further used as a soap and for ethnoveterinary purposes 
(Gerstner, 1938).  Contrasting reports on the toxicity of this species to mammalian 
test subjects exist (Steyn, 1936; Van der Walt and Steyn, 1941).  The second subject 
of this investigation, Ledebouria socialis (Bak.) Jessop is localised in the Eastern 
Cape Province of South Africa, and exists as both green and silver-leaved forms.  
From the ethyl acetate extract of Ledebouria socialis (as Scilla socialis Bak.), Kato et 
al., (2007) yielded eleven hyacinthacines, two pyrrolidines and three piperidines.  The 
methanol extract of Ledebouria ovatifolia earlier yielded two compounds 4,4′-
dihydroxy-2′,6′-dimethoxychalcone and 5,7-dihydroxy-3-(4′-hydroxybenzyl)-4-
chromanone (Pohl et al., 2001).  
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Cyclooxygenase is responsible for the synthesis of prostaglandins in acute 
inflammatory conditions (O’Banion et al., 1992).  Non-selective inhibitors of 
cyclooxygenase decrease the inflammatory response but have also been linked to 
gastro-intestinal tract bleeding at high doses (Smith et al., 2000). Selective COX-2 
inhibitors decreased this effect but were found to have cardiac implications (Cipollone 
et al., 2008).  It has also been demonstrated in several studies that cyclooxygenase 
inhibitors can have cancer preventative effects (Giardiello et al., 1995;  Levy, 1997) 
especially when specific against cyclooxygenase-2.  
 
As the Hyacinthoideae has been shown to contain anti-inflammatory 
homoisoflavanones using the mouse oedema test (Della Loggia et al., 1989), the 
homoisoflavanones and xanthones isolated from the two plants were screened for 
cyclooxygenase activity.  Reported herein is the isolation of five novel compounds 
along with twenty-five known compounds from the bulbs of both L. socialis and L. 
ovatifolia.  The anti-inflammatory activities of selected isolates were evaluated. 
 
2. Results and discussion: 
The dichloromethane extract of the bulbs of L. socialis was separated by normal phase 
column chromatography over silica gel to afford one novel homoisoflavanone, 
socialinone (1) as well as (R)-5-hydroxy-7,2’,3’,4’-tetramethoxyspiro{2H-1-
benzopyran-3-(4H)-9-bicyclo[4.2.0]octa[1,3,5]-triene}-4-one, isolated previously 
from Drimiopsis barteri (Ngamga et al., 2008), and phytol and stigmasterol.  The 
methanol extract was separated using normal phase column chromatography and 
yielded the known compound polybotrin (Zou et al., 2007), which has not been 
reported previously from the Hyacinthaceae.  The dichloromethane, ethyl acetate and 
methanol extracts of bulbs of L. ovatifolia were separated by normal phase column 
chromatography over silica gel to afford twenty-five compounds.  The 
dichloromethane extract yielded compound 2, reported previously (Kawasaki et al., 
1973) as a mixture of diastereomers, which we separated after acetylation and were 
able to assign the respective absolute configurations using 2D NMR and CD 
spectroscopy, a novel dihydro-chalcone (3), and a novel xanthone (4).  Also isolated 
from this extract were the known compounds (R)-5,7-dihydroxy-3-(4′-
hydroxybenzyl)chroman-4-one (Adinolfi et al., 1987) and (E)-4,4′-dihydroxy-2′,6′-
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dimethoxychalcone (Sun et al., 1989) which had both been isolated previously from 
Ledebouria ovatifolia (Pohl et al., 2001), scillascillin (Kawasaki et al., 1973), 1,6-
dihydroxy-3-methoxy-8-methyl-9H-xanthen-9-one (McMaster et al., 1960; 
Mutanyatta et al., 2003), (R)-4’,5,7-trihydroxy-3’-methoxyspiro{2H-1-benzopyran-
3(4H)-9-bicyclo[4.2.0]octa[1,3,5]triene}-4-one (Adinolfi et al., 1985), (R)-3’,5,7-
trihydroxy-4’-methoxyspiro{2H-1-benzopyran-3(4H)-9-
bicyclo[4.2.0]octa[1,3,5]triene}-4-one (Adinolfi et al., 1987), (R)-5,7-dihydroxy-3-
(4’-methoxybenzyl)chroman-4-one (Heller et al., 1976), eucomol  (Bohler and Tamm, 
1967), and (R)-7-hydroxy-3-(4’-hydroxybenzyl)-5-methoxychroman-4-one (Finckh 
and Tamm, 1970) which had been isolated previously from the Hyacinthaceae, and 
coniferaldehyde (Seikel et al., 1971) and chondrillasterol (Bergmann and Feeney, 
1948) which had not been isolated previously from this family.  The ethyl acetate 
extract yielded one novel homoisoflavanone, ovatifolionone (5), and the known 
compounds, drimiopsin C (Mulholland et al., 2004), norlichexanthone 
(Aghoramurthy and Seshadri, 1953; Mutanyatta et al., 2003), 22-acetoxy-15-
deoxoeucosterol (Amschler et al., 1997; Pohl et al., 2001), (R)-(3-(3’,4’-
dihydroxybenzyl)-5,7-dihydroxychroman-4-one (Adinolfi et al., 1987, 4’-demethyl-5-
O-methyl-dihydroeucomin (Finckh and Tamm, 1970), (R)-3-(3’,4’-dihydroxybenzyl)-
7-hydroxy-5-methoxychroman-4-one (Adinolfi et al., 1987), and (E)-3-(3’,4’-
dihydroxybenzylidene)-7-hydroxy-5-methoxychroman-4-one (Masterova et al., 1991) 
which have all been isolated from the Hyacinthaceae previously and p-anisic aldehyde 
(Gottlieb et al., 1970) and 4-hydroxyphenylethanol (Gharbo et al., 1970) which have 
not been reported from this family.  The methanol extract also yielded polybotrin 
(Zou et al., 2007).  Interestingly, this compound was isolated from both species in this 
study.  The known compounds were identified by analysis of their spectroscopic and 
spectrometric data and comparison with literature data.   
Compound 1, (R)-2’,5-dihydroxy-3’,4’,7-trimethoxyspiro{2H-1-benzopyran-3-(4H)-
9-bicyclo[4.2.0]octa[1,3,5]triene}-4-one, was obtained as a yellow oil.  The IR 
absorption bands at 3455 and 1737 cm-1 indicated the presence of hydroxyl and 
carbonyl functional groups, respectively.  This compound was identified as the 2’-
hydroxylated derivative of the known 5-hydroxy-7,2’,3’,4’-tetramethoxyspiro{2H-1-
benzopyran-3-(4H)-9--bicyclo[4.2.0]octa[1,3,5]-triene}-4-one (Ngamga et al., 2008), 
also isolated in this work.  The 1H NMR spectrum showed a sharp resonance at δ 
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12.05 ascribable to the hydrogen bonded hydroxyl group proton at C-5, two meta-
coupled proton resonances (δ 6.09, d, J = 2.3 Hz, δ 6.05, d, J = 2.3 Hz) ascribable to 
H-6 and H-8, resonances ascribed to the two H-2 (2H, δ 4.55) and two H-9 (δ 3.62, d, 
J = 13.1 Hz, δ 3.02, d,  J = 13.1  Hz) resonances of a scillascillin-type of 
homoisoflavonoid.  The H-5’ resonance (δ 6.29, s) showed  correlations in the HMBC 
spectrum with C-3, C-3’ and C-1’ resonances.  A hydroxyl group was placed at C-2’ 
due to correlations between the hydroxyl group proton resonance (δ 5.84, s) and the 
C-1’and C-3’ resonances in the HMBC spectrum.  Methoxy groups (δ 3.84, δ 3.80, δ 
3.86) were placed, in agreement with the NOESY spectrum, at the remaining C-7, C-
4’ and C-3’ positions.  The ECD spectrum of Compound 1 showed a positive Cotton 
effect at 297 nm and a negative Cotton effect at 340 nm confirming the (R)-
configuration at C-3 (Adinolfi et al., 1990). 
Compound 2 is the C-2 hydroxylated, C-3’/C-4’-methylenedioxy derivative of 
Compound 1.  The hemiacetal ring C opens and closes in solution, making it 
impossible to obtain a pure compound.  Acetylation yielded compounds 2(R) and 2(S) 
which could be separated, and the absolute configuration at C-2  of the diastereomers 
was confirmed using NMR and CD experiments. Compound 2 has previously been 
reported from Barnardia japonica (as Scilla scilloides) (Kawasaki et al., 1973). 
Compound 2(R), the 2,5-diacetoxy derivative of 2, was isolated as a clear oil.  The 1H 
NMR spectrum showed the H-2 resonance (δ 6.48, s) and the typical H-9 proton 
resonances (δ 3.33, d, J=13.5 Hz,δ 3.20, d, J=13.5 Hz).    Resonances at δ 6.67 and δ 
6.61 appeared as singlets indicating their para-relationship and were assigned as H-2’ 
and H-5’ respectively.  Resonances due to protons of a C-3’/C-4’ methylenedioxy 
group were seen at δ 5.91 and δ 5.89 (both d, J=1.3 Hz) .  The NMR spectra of 
compound 2(S), differed slightly in the chemical shifts for H-2, 2H-9, H-2’ and H-5’ 
as shown in Table 1.  The absolute configuration at C-2 of 2(R) and 2(S) was 
established using ECD experiments.  Compound 2(R) showed a negative Cotton 
effect at 300 nm and Compound 2(S) a positive Cotton effect at 307 nm.  The 
experimental ECD spectra of the two compounds were compared to their calculated 
spectra.  Conformational analysis of compounds 2(R) and 2(S) were performed on 
Spartan08 using MMFF (Devlin et al., 2009) and the global minimum conformers 
subjected to TDDFT calculations employing the functional B3LYP and a basis set of 
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6-31G (d, f), built into Gaussian09 software (Burgueno-Tapia et al., 2006; Felippe et 
al., 2012). The calculated ECD spectra of the global minimum conformers were 
compared to the experimental spectra [Figure 2].  The TDDFT simulated and 
experimental ECD spectra of compound 2(R) were compared and both showed 
negative Cotton effects at 230-400 nm confirming that compound 2(R) had the 2R, 3R 
configuration.  The TDDFT simulated ECD spectrum obtained for Compound 2(S) 
was UV corrected and compared to the experimental ECD spectrum supporting a (2S, 
3R) configuration for Compound 2(S) [Figure 2].  
Compound 3, 4,4’-dihydroxy-2’,6’-dimethoxydihydrochalcone, was isolated as a 
white powder from the dichloromethane extract of L. ovatifolia. HRESIMS indicated 
a molecular formula of C17H18O5 and IR absorption bands at 3377 and 1736 cm-1 
indicated hydroxyl and carbonyl groups.   Two coupled methylene proton resonances 
(2H, δ 2.92, t, J=7.7 Hz; 2H, δ 3.01, t, J=7.7 Hz) indicated a dihydrochalcone 
structure.  Para-substitution on ring C was confirmed by the presence of a pair of 
doublets, each integrating to 2H (δ 7.07, d, J= 8.5 Hz; δ 6.73, d, J= 8.5 Hz).  Two 
equivalent methoxy groups (6H, δ 3.71, s) were placed at C-2’ and C-6’ in agreement 
with correlations seen in the NOESY spectrum with the H-3’/5’ resonance (2H, δ 
6.02, s), and 2Hα. The remaining two hydroxyl groups were placed at C-4 and C-4’. 
Compound 4, 1,6-dihydroxy-2,3,5-trimethoxy-8-methyl-9H-xanthen-9-one, was 
isolated as a yellow powder from the CH2Cl2 extract of L. ovatifolia.  HRESIMS 
indicated a molecular formula of C17H16O7 and IR absorption bands 3417 and 1643 
cm-1 indicated the presence of hydroxyl and carbonyl groups.  The 1H NMR spectrum 
showed hydrogen bonding between the C-9 carbonyl group and a C-1 hydroxyl group 
proton (δ 13.26, s, H-1-OH).  The C-8 methyl group proton resonance (δ 2.80, 
s)(Mulholland et al., 2004), showed correlations in the COSY and NOESY spectra 
with the H-7 resonance (δ 6.75, s).  The NOESY spectrum showed correlations 
between the H-7/C-6-OH (δ 6.24, s), H-6-OH/C-5-OMe(δ 4.05, s), C-5-OMe/H-4 (δ 
6.46, s)and H-4/C-3-OMe (δ 3.97, s) proton resonances.  The remaining methoxy 
group (δ 3.91, s) was placed at C-2. This was confirmed by an HMBC correlation 
between the C-2 (δ 132.2) and the H-4 resonances. 
Compound 5, ovatifolionone, a 3-benzylidene-4-chromanone homoisoflavanone, was 
isolated as a yellow powder from the EtOAc extract of L. ovatifolia.  Compound 5 
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was acetylated to aid purification and formed a mono-acetate (5Ac).  The molecular 
ion was not observed in the HRESIMS, but a peak at 299.0553, corresponding to a 
[M-OAc]+ ion was observed.   The IR absorption bands at 3415, 1745 and 1638 cm-1 
indicated  hydroxyl, and acetate and ketone carbonyl stretches  respectively.  1H NMR 
and 13C NMR spectra indicated a C-3(9)-double bond, with the H-9 resonance 
occurring as a singlet at δ 7.58.  The H-2 resonance (2H, δ 5.30, d, J=1.4 Hz) showed 
a correlation in the COSY spectrum with the H-9 resonance and the C-3 resonance 
was observed as a quaternary carbon at δ 128.9.  As no hydrogen-bonded 5-OH 
proton resonance was present, the acetate group was placed at C-5.  This placement 
was confirmed by the chemical shift of the C-4 carbonyl carbon resonance which 
occurred at δ 180.4 compared to the usual value of δ 186 for 5-OH benzylidene 
homoisoflavanones  (Bangani et al., 1999).  Resonances due to the meta-coupled H-6 
and H-8 protons occurred at δ 6.19 and δ 6.26 respectively (both d, J= 2.3 Hz).  The 
ring C protons exhibited an ABX pattern (6.80, d, J=1.8 Hz, H-2’; δ 6.85, d, J=8.2 
Hz; δ 6.76, dd, J= 8.2, 1.8 Hz), and the remaining hydroxyl groups were placed at C-
3’ and C-4’.  The configuration of the double bond was established as E from the 
distinctive chemical shift of the H-9 resonance (δ 7.58) (Masterova et al., 1991). 
Isolates 1-5Ac, as well as ten known compounds re-isolated in this work (6-15) were 
screened for cyclo-oxygenase-2 (COX-2) inhibitory activity.  Two COX isoenzyme-
specific inhibitors were used as positive controls, namely SC-560 and DuP-697 
(Cayman Chemical Company, 2011), and these compounds were shown to be 
selective for COX-1 and COX-2 isoenzymes in the assay system that was utilised 
(Figure 2 and Table 3).  Compounds 5Ac, 6, 7 and 10, showed significant COX-2 
inhibitory activity when screened at 10 µM. The compounds which showed inhibitory 
activity for COX-2 were screened against cyclooxygenase-1 (COX-1) to measure 
their selectivity for the COX-2 enzyme. Compounds 6 and 7 were found to be non-
specific inhibitors of both the COX-1 and COX-2 enzyme during these studies.  
Compound 10, (E)-3-(3’,4’-dihydroxybenzylidene)-7-hydroxy-5-methoxychroman-4-
one, however, was completely selective for COX-2 at a concentration of 10 µM, and 
had an IC50 for COX-2 of 2.87 µM ± 1.2.  Compound 5Ac was partially selective, 
inhibiting COX-1 with an IC50 of 2.56 µM ±1.2 and COX-2 with an IC50 of 1.12 µM 
± 0.56 µM.  The COX-2 specific inhibitor DuP-697 had an IC50 value of 40 nM, 
which is substantially lower than those shown above. However, the isolates show IC50 
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values which are within the range of widely used and non-selective inhibitors such 
asparacetamol (acetaminophen) (IC50 26 µM for COX-2) (Hinz et al., 2008).. It can 
therefore be concluded that the isolates above could be therapeutically valuable and 
that compound 10 could be developed into a clinically relevant and COX-2 specific 
inhibitor. 
3. Experimental 
3.1 General Experimental Procedures 
1D and 2D NMR spectra were recorded in CDCl3 and  CD3OD on a 500 MHz Bruker 
AVANCE NMR instrument at room temperature.  Chemical shifts (δ) are expressed 
in ppm and were referenced to the solvent references at 7.26 and 77.23 ppm for 
CDCl3, 4.87 and 49.15 ppm for CD3OD  for 1H NMR and 13C NMR respectively.  
ESI mass spectra were recorded on a Bruker MicroToF mass spectrometer using an 
Agilent 1100 HPLC to introduce samples (University of Oxford), optical rotations 
were determined in CHCl3 on a JASCO P-1020 polarimeter (University of Surrey), IR 
spectra were recorded using a Perkin-Elmer 2000 spectrometer, and UV and CD 
spectra were obtained on a Chirascan spectropolarimeter at room temperature using a 
1 cm cell in MeOH. 
 
3.2 Plant Material 
Ledebouria ovatifolia (Bak.) Jessop bulbs (1.0 kg) were purchased from the medicinal 
plant market in Johannesburg, Gauteng in November 2007 and a flowering voucher 
retained (N. Crouch 1278, NH).  Bulbs of cultivated Ledebouria socialis (Bak.) 
Jessop (silver-leaved form)(1.0 kg) were harvested during January 2007 and a 
voucher retained (N. Crouch 1118, NH).  Plant materials were identified by Professor 
N. Crouch of the South African National Biodiversity Institute (SANBI).     
3.3 Extraction and Isolation of Compounds 
The air-dried bulbs of L. socialis were chopped and extracted using dichloromethane 
and methanol successively on a shaker for 48 hours.  Evaporation of the solvents in 
vacuo yielded dichloromethane (1.47 g) and methanol (7.50 g) extracts.  Column 
chromatography of both extracts was performed over silica gel (Merck 9385) using a 
5 cm diameter gravity column, collecting fractions (75 ml each) using a 
hexane/dichloromethane stepwise gradient followed by a dichloromethane/ methanol 
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stepwise gradient. Preparative TLC on 0.2 mm silica gel, aluminium backed plates 
(Merck Art. 5554) was subsequently used. Compounds were detected using a UV-
lamp or, where necessary, a section of the plate was developed using anisaldehyde 
spray reagent, with subsequent heating. Final purification was undertaken using a 1 
cm diameter column.  The dichloromethane extract yielded compound 1 (Fraction 
189-198, 53.9 mg, followed by preparative TLC in 10% EtOAc/DCM, eluted twice) 
as well as known compounds (R)-5-hydroxy-7,2’,3’,4’-tetramethoxyspiro{2H-1-
benzopyran-3-(4H)-9-bicyclo[4.2.0]octa[1,3,5]-triene}-4-one (34.7 mg), phytol and 
stigmasterol.  The methanol extract yielded only the known compound polybotrin (1.8 
mg).   
 
The bulbs of L. ovatifolia were extracted using dichloromethane, ethyl acetate and 
methanol successively on a shaker for 48 hours.  After evaporation of the solvents in 
vacuo the following extracts were obtained: dichloromethane (19.65 g), ethyl acetate 
(11.56 g) and methanol (54.95 g).  Column chromatography over silica gel (Merck 
9385) using a 5 cm diameter gravity column, collecting fractions (75 ml each) using a 
hexane/dichloromethane stepwise gradient followed by a dichloromethane/ methanol 
stepwise gradient, was used to separate the constituents.  Final purification was 
undertaken using a 1 cm diameter column.  The dichloromethane extract yielded 
compound 2 (Fractions 140-145, 20 mg, 98% CH2Cl2/ 2% diethyl ether, compound 3 
(Fraction 237-248, 2.1 mg, 20% diethyl ether/ 80% CH2Cl2),  and compound 4 
(Fractions 140-145, 6.7mg, 90% CH2Cl2/ 10% diethyl ether) as well as known 
compounds (R)-5,7-dihydroxy-3-(4′-hydroxybenzyl)chroman-4-one (10.2 mg), (E)-
4,4′-dihydroxy-2′,6′-dimethoxychalcone (6.3 mg), scillascillin (1.3 mg), 1,6-
dihydroxy-3-methoxy-8-methyl-9H-xanthen-9-one (2.2 mg), (R)-4’,5,7-trihydroxy-3’-
methoxyspiro{2H-1-benzopyran-3(4H)-9-bicyclo[4.2.0]octa[1,3,5]triene}-4-one (2.6 
mg), (R)-3’,5,7-trihydroxy-4’-methoxyspiro{2H-1-benzopyran-3(4H)-9-
bicyclo[4.2.0]octa[1,3,5]triene}-4-one (4.5 mg), (R)-5,7-dihydroxy-3-(4’-
methoxybenzyl)chroman-4-one (7.3 mg), eucomol (4.4 mg), (R)-7-hydroxy-3-(4’-
hydroxybenzyl)-5-methoxychroman-4-one (6.9 mg), coniferaldehyde (0.5 mg) and 
chondrillasterol (18.7 mg). The ethyl acetate extract yielded compound 5 (Fraction 
61-75, 3 mg,100% CH2Cl2) and known compounds drimiopsin C (12.8 mg), 
norlichexanthone (2 mg), 22-acetoxy-15-deoxoeucosterol (6 mg), (R)-(3-(3’,4’-
dihydroxybenzyl)-5,7-dihydroxychroman-4-one (7.8 mg), 4’-demethyl-5-O-methyl-
 10
dihydroeucomin (13.3 mg), (R)-3-(3’,4’-dihydroxybenzyl)-7-hydroxy-5-
methoxychroman-4-one (370 mg)   (E)-3-(3’,4’-dihydroxybenzylidene)-7-hydroxy-5-
methoxychroman-4-one (7.5 mg), p-anisic aldehyde (5.2 mg) and 4-
hydroxyphenylethanol (1.1 mg).  The methanol extract yielded only the known 
compound polybotrin (7.0 mg). 
3.3.1         (R)-2’,5-dihydroxy-3’,4’,7-trimethoxyspiro{2H-1-benzopyran-3-(4H)-9-
bicyclo[4.2.0]octa[1,3,5]triene}-4-one (1)  
Yellow oil; [α]D23.6 +40 (c 0.005, CHCl3); CD data (c 0.001, MeOH) 297 nm (+1.51), 
340 nm (-1.75); UV (CDCl3) λmax 240, 290 nm; IR νmax (NaCl) cm-1 3455, 2959, 
2929, 2860, 1737, 1462, 1380, 1242, 1174, 1078, 665; 1H (500 MHz, CDCl3) and 13C 
NMR (125 MHz, CDCl3) spectroscopic data, see Table 1; HRESIMS m/z 381.0948 
[M+Na]+ (calc. for C19H18O7Na 381.0945). 
3.3.2 (2R,3R)-2,5-diacetoxy-7-methoxyspiro[2H-1-benzopyran-3(4H), 5’(6’H)-
cyclobuta[f][1,3]benzodioxol]-4-one (2(R) 
Clear oil; [α]D23.6 -172 (c 0.006, CHCl3); CD data (c 0.001, MeOH) 275 nm (-2.22),  
300 nm (-6.80); UV (CDCl3) λmax  290 nm; IR νmax (NaCl) cm-1 2975, 2927, 2898, 
1758, 1649, 1624, 1571, 1455, 1381, 1317, 1271, 1233, 1152, 1088, 1048, 880, 805, 
739, 666; 1H (500 MHz, CDCl3) and 13C NMR (125 MHz, CDCl3) spectroscopic data, 
see Table 1; HRESIMS m/z 449.0843 [M+Na]+ (calc. for C22H18O9Na 449.0843).  
3.3.3 (2S,3R)-2, 5-diacetoxy-7-methoxyspiro[2H-1-benzopyran-3(4H), 5’(6’H)-
cyclobuta[f][1,3]benzodioxol]-4-one (2(S)) 
Clear oil; [α]D23.6 +173 (c 0.010, CHCl3); CD data (c 0.001, MeOH)  275 nm (-1.68), 
307 nm (+8.92); UV (CDCl3) λmax 300, 270 nm; IR νmax (NaCl) cm-1 2922, 2850, 
1758, 1686, 1619, 1570, 1457, 1369, 1302, 1269, 1233, 1194, 1152, 1106, 1036, 
1007, 971, 937, 886, 846, 811, 754, 666; 1H (500 MHz, CDCl3) and 13C NMR (125 
MHz, CDCl3) spectroscopic data, see Table 1; HRESIMS m/z 449.0842 [M+Na]+ 
(calc. for C22H18O9Na 449.0843).  
 
3.3.3.1 Acetylation of 2-hydroxy-7-O-methylscillascillin (2) 
Compound 2 (20 mg) was dissolved in pyridine (3 ml), acetic anhydride (3 ml) was 
added and the mixture was left to stand for 12h. MeOH (2 x 5 ml) was added and 
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solvent was removed under vacuum. The residue was subsequently purified using 
preparative TLC (40% hexane: 58% CH2Cl2: 2% diethyl ether) to yield 2(R) (6 mg) 
and 2(S) (10 mg). 
3.3.4   4’,4-Dihydroxy-2’,6’-dimethoxydihydrochalcone (3)  
White amorphous powder; UV (CDCl3) λmax 280 nm; IR νmax (NaCl) cm-1 3377, 2953, 
2924, 2854, 2356, 2336, 1736, 1676, 1598, 1513, 1463, 1370, 1247, 1220, 1166, 
1126, 1032, 996, 827, 756; 1H NMR (500 MHz, CDCl3) δ 7.07 (2H, d, J= 8.5 Hz, 
2/6), δ 6.73 (2H, d, J=8.5 Hz, 3/5), δ 6.02 (2H, s, 3’/5’), δ 3.71 (3H, s, 2’/6’-OCH3), δ 
3.01 (2H, t, 7.7 Hz, α),  δ 2.92 (2H, t, 7.7 Hz, β) and 13C NMR (125 MHz, CDCl3), δ 
203.1 (C=O), δ 158.7 (C, 2’/6’), δ 158.7 (C, 4’), δ 153.6 (C, 4),  δ 133.7 (C, 1), δ 
129.9 (2-CH, 2/6), δ 112.8 (C, 1’), δ 115.5 (2-CH, 3/5), δ 92.3 (2-CH, 3’/5’), δ 56.2 
(CH3, 2’/6’-OCH3), δ 46.9 (CH2, α), δ 29.4 (CH2, β); HRESIMS m/z 325.1045 
[M+Na]+ (calc. for C17H18O5Na 325.1046). 
 
3.3.5 1,6-dihydroxy-2,3,5-trimethoxy-8-methyl-9H-xanthen-9-one (4) 
Yellow amorphous powder; UV (CDCl3) λmax 310, 250 nm; IR νmax (NaCl) cm-1 3417, 
2922, 2850, 2101, 1643, 1311, 1454, 1511, 1209, 1181, 1153, 1123, 1072, 1035, 987; 
1H NMR (500 MHz, CDCl3) spectroscopic data δ 13.26 (1H, s, 1-OH), δ 6.75 (1H, s, 
7), δ 6.46 (1H, s, 4), δ 6.24 (1H, s, 6-OH), δ 4.05 (3H, s, 5-OMe), δ 3.97 (3H, s, 3-
OMe),  δ 3.91 (3H, s, 2-OMe), δ 2.80 (3H, s, 8-CH3); 13C NMR (125 MHz, CDCl3) 
spectroscopic data δ 182.9 (C, 9); δ 159.4 (C, 3), δ 155.0 (C, 1), δ 153.2 (C, 6), δ 
152.3 (C, 4a), δ 151.2 (C, 5a), δ 138.5 (C, 8), δ 132.2 (C, 5/2), δ 114.9 (CH, 7), δ 
104.5 (C, 1a), δ 90.1 (CH, 4), δ 62.1 (CH3, 2-OMe), δ 61.1 (CH3, 3-OMe), δ 56.5 
(CH3, 5-OMe), δ 23.4 (CH3, 8-CH3), HRESIMS m/z 355.0787 [M+Na]+ (calc. for 
C17H16O7Na 355.0788). 
 
3.3.6 (E)-3-(3’,4’-dihydroxybenzylidene)-5-acetoxy-7-hydroxychroman-4-one 
(ovatifolionone acetate) (5Ac) Yellow amorphous powder; UV (CDCl3) λmax 280, 360 
nm; IR νmax (NaCl) cm-1 3582, 3415, 2957, 2920, 2361, 2336 1745, 1638, 1512,1461, 
1447, 1370, 1259, 1202, 1162, 1115; 1H NMR (500 MHz, CDCl3) and 13C NMR (125 
MHz, CDCl3) spectroscopic data for 5Ac, see Table 1; HRESIMS m/z 299.0553 [M-
OAc]- (calc. for C16H11O6 299.0561). 
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3.3.6.1 Acetylation of (E)-3-(3,4-dihydroxybenzylidene)-5,7-dihydroxychroman-4-one 
(5) 
Compound 5 (3 mg) was acetylated using the method described in section 3.3.4.1 and 
purified using normal phase column chromatography (100% CH2Cl2) to yield 
Compound 5Ac (1.8 mg). 
3.4 Assay for inhibition of COX activity 
Assays were performed in a 96-well plate with purified COX-1 from ram seminal 
vesicles (Sigma Aldrich UK, C0733, >40000 units/mg) or human purified COX-2 
(Sigma Aldrich UK, C0858, >8000 units/mg ).  COX enzymes were used after a 1/3 
dilution into buffer (0.1 M Tris. HCl, pH 8) and 5 µl of the diluted solution was used 
in a 200 µl total volume. 
 
Cyclooxygenase inhibition was assayed using the Cayman Fluorescence activity kit © 
guidelines (Cayman Chemical Company, 2011) measured by the conversion of PGG2 
to PGH2 via the fluorescence of an additive called Amplex Red (Cayman Chemical 
Co., A1111, 5 mg, final assay concentration of 100 µM).  Inhibition of COX refers to 
a reduction of PGH2 formation, demonstrated by a reduction in fluorescence, in 
comparison to a non-inhibitor control (Batchelor et al., 2003).  DuP-697 (Cayman 
Chemical Co., 760158, 5 mg, 304 nM final assay concentration) and SC-560 
(Cayman Chemical Co., 70340, 5 mg, 354 nM final assay concentration) were used as 
positive inhibitor controls for COX-1 and COX-2 respectively (Cayman Chemical 
Company, 2011).  
 
Other additives included the substrate, arachidonic acid (Sigma Aldrich, A9673, 10 
mg, 100 µM final assay concentration), the cofactor hematin (Sigma Aldrich, H3281, 
250 mg, 100 µM final assay concentration) and buffer (0.1 M, Tris. HCl, pH 8). 
The study was performed on a SpectraMax Gemini XS (Molecular Devices) well-
plate fluorimeter using SoftMax Pro software.  The fluorimeter takes 96-well plates 
and was set to read at 535 nm and 595 nm excitation and emission wavelengths, with 
a cut-off filter at 550 nm, set manually.  Automix was turned on for two seconds 
before each run.  The readings were taken in the ‘normal’ range (5), at medium 
sensitivity when using the COX-2 enzyme and low sensitivity when using the COX-1 
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enzyme.  Each assay was run for 300 seconds with intervals ranging from 3-10 
seconds depending on the number of wells measured. 
 
 3.4.1 Sample Preparation 
Samples were dissolved to make a 20 mM solution in ethanol, of which 1 µl was 
diluted with 100 µl buffer to give a 200 µM solution.  10 µl of the latter solution was 
used in a total assay volume of 200 µl to give a final concentration of 10 µM. 
Compounds were tested at a screening concentration of 10 µM and compounds 
showing activity and no inhibitory activity for COX-1 at this concentration were 
subjected to IC50 determination.  
 
3.5 Computational methods  
The conformational searches for Compounds 2(R) and 2(S) were carried out at the 
molecular mechanics level of theory employing MMFF force field incorporated in the 
Spartan08 (Wavefunction, Irvine, CA) software package. Global minimum 
conformers were subjected to TDDFT calculations using a B3LYP method at 6-31G 
(d, f) level built in to Gaussian09 software (Frisch, et al., 2010). The simulated ECD 
curves were UV-corrected where necessary and compared to the experimental ECD 
curves.  
 
4. Supplementary information 
Supplementary data associated with this article can be found, in the online version, 
XXXXXXXXXXX.  
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Figure 1. Compounds isolated from Ledebouria socialis and Ledebouria ovatifolia 
and screened in COX-1 and COX-2 assay  
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Fig. 2 The experimental and modelled circular dichroism analysis of Compound 2  
 20
 
Table 2: The percentage cyclooxygenase-2 activity of Compounds 1-3 and 5Ac-13 
 
Compound COX-2 % activity at 10µM COX-1 % activity at 10µM 
1 101.1% ± 32.6%  
2(R) 66.7% ± 17.5%  
2(S) 89.0% ± 29.2%  
3 54.4% ± 25.7%  
5 acetate 0% ± 7.8% 57% ± 10.2% 
6 0% ± 21.3% 56% ± 10.7% 
7 0% ± 5.4% 54% ±15.1% 
8 73.8% ± 21.4%  
9 62.2% ± 21.4%  
10 0% ± 8.3% 73.8% ± 8.0% 
11 13.3% ± 13.3%  
12 20.9% ± 13.0%  
13 71.4% ± 20.0%  
   
Controls*:   
DuP-697 47.0% ± 15.5% 83.8±0.9% 
SC-560 76.7±16.0% 56.7% ± 3.5% 
   
   
 
*Footnote 
Compounds SC-560 and DuP-607 are positive controls for COX-1 and COX-2 
respectively (Cayman Chemical Company, 2011).  SC-560 at a concentration of 354 
nM had a significant inhibitory effect on COX-1, but not COX-2, enzyme activity.  
Similarly, DuP-607 at 304 nM had a significant effect on COX-2 and not COX-1. 
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Fig. 3 The percentage cyclooxygenase-2 activity of Compounds 1-3 and 5 acetate-13 
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Table 1: 1H NMR (500 MHz) and 13C NMR (125 MHz) data for compounds 1, 2(R) and 2(S) (in CDCl3) and 5 acetate (in MeOD)  
 
No. 1 2(R) 2(S) 5 acetate 
13C NMR  1H NMR  13C NMR  1H NMR  13C NMR  1H NMR  13C NMR  1H NMR 
2A 
2B 
73.7 CH2 4.55* 
4.54* 
97.1 CH 6.48, s 96.7 CH 6.58, s 67.9 CH2 5.30, d, J = 1.4 Hz 
3 54.5 C  56.6 C  57.3 C  128.9 C  
4 196.2 C  188.2 C  185.9 C  180.4 C  
4a 102.4 C  107.2 C  107.2 C  165.4 C  
5 164.9 C  151.9 C  152.1 C  170.4 C  
6 95.4 CH 6.09, d, J = 2.3 Hz 105.8 CH 6.33, d, J = 2.4 Hz 105.8 CH 6.36, d, J = 2.4 Hz 105.9 CH 6.19, d, J=2.3 Hz 
7 168.2 C  165.9 C  166.0 C  153.1 C  
8 94.4 CH 6.05, d, J = 2.3 Hz 100.6 CH 6.43, d, J = 2.4 Hz 100.5 CH 6.48, d, J = 2.4 Hz 101.4 CH 6.26,s** 
8a 163.3 C  160.0 C  160.0 C  164.5 C  
9A 
9B 
33.6 CH2 3.02, d,  J = 13.1  Hz 
3.62, d, J = 13.1 Hz 
37.6 CH2 3.33, d, J = 13.5 Hz 
3.20, d, J = 13.5 Hz 
31.1 CH2 3.84, d, J = 13.9 Hz 
2.74, d, J = 13.9 Hz 
137.5 CH 7.58, s 
1’ 118.0 C  133.8 C  135.5 C  147.9 C  
2’ 145.2 C  105.7 CH 6.67, s 103.9 CH 6.42, s 123.6 CH 6.80,d, J= 1.8 Hz 
3’ 137.1 C  149.3 C  148.9 C  145.8 C  
4’ 154.0 C  148.0 C  147.2 C  126.8 C  
5’ 99.4 CH 6.29 s 105.2 CH 6.61, s 106.1 CH 6.67, s 115.7 CH 6.85, d, J = 8.2 Hz 
6’ 139.2 C  131.8 C  134.8 C  117.4 CH 6.76, dd, J = 8.2, 1.8 Hz 
7’A 
7’B 
  100.3 CH2 5.91, d, J = 1.3 Hz 
5.89, d, J = 1.3 Hz 
100.3 CH2 5.86, d, J = 1.2  Hz,  
5.82, d, J = 1.2  Hz, 
  
7-OCH3 56.0 CH3 3.84 s 56.2 CH3 3.84, s 56.2 CH3 3.86, s   
5-COOCH3   21.1 CH3 2.09, s 21.1 CH3 2.06, s 20.3 CH3 2.33, s 
5-COOCH3   169.5 C  169.5 C  170.4 C  
5-OH  12.05 s       
2-COOCH3   21.3 CH3 2.32, s 21.3 CH3 2.33, s   
2-COOCH3   169.6 C  169.7 C    
2’-OH  5.84, s       
3’-OCH3 61.3 CH3 3.86, s       
4’-OCH3 56.5 CH3 3.80, s       
*non-first order coupling 
**
 doublet unresolved 
 
